ºÝºÝߣshows by User: petlifepharma / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: petlifepharma / Thu, 10 Nov 2016 06:40:23 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: petlifepharma Pet life pharmaceuticals is pleased to announce the completion of the new company website /slideshow/pet-life-pharmaceuticals-is-pleased-to-announce-the-completion-of-the-new-company-website/68547193 petlifepharmaceuticalsispleasedtoannouncethecompletionofthenewcompanywebsite-161110064023
Hancock, MD, Oct. 17, 2016 - PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and Nutraceuticals for pets, has completed the corporate website overhaul as FDA/CVM submission and testing nears.]]>
Hancock, MD, Oct. 17, 2016 - PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and Nutraceuticals for pets, has completed the corporate website overhaul as FDA/CVM submission and testing nears.]]> Thu, 10 Nov 2016 06:40:23 GMT /slideshow/pet-life-pharmaceuticals-is-pleased-to-announce-the-completion-of-the-new-company-website/68547193 petlifepharma@slideshare.net(petlifepharma) Pet life pharmaceuticals is pleased to announce the completion of the new company website petlifepharma Hancock, MD, Oct. 17, 2016 - PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and Nutraceuticals for pets, has completed the corporate website overhaul as FDA/CVM submission and testing nears. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/petlifepharmaceuticalsispleasedtoannouncethecompletionofthenewcompanywebsite-161110064023-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Hancock, MD, Oct. 17, 2016 - PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the &quot;Company&quot;), a developer of a new generation of high potency veterinary cancer medications and Nutraceuticals for pets, has completed the corporate website overhaul as FDA/CVM submission and testing nears.
Pet life pharmaceuticals is pleased to announce the completion of the new company website from PetLife Pharmaceuticals Inc
]]> 73 3 https://cdn.slidesharecdn.com/ss_thumbnails/petlifepharmaceuticalsispleasedtoannouncethecompletionofthenewcompanywebsite-161110064023-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Stages of Production of Escozine For Petsâ„¢ /slideshow/stages-of-production-of-escozine-for-pets/68041394 stagesofproduction-161102071524
Escozine for Petsâ„¢ has 4 major production steps. 1. Collection of Scorpions from the Scorpion Reservation. 2. Extraction of venom, purification and therapeutic dose preparation. 3. Polarization of extract and quality control of Polarization 4. Manufacturing, quality control, warehouse and shipment. ]]>
Escozine for Petsâ„¢ has 4 major production steps. 1. Collection of Scorpions from the Scorpion Reservation. 2. Extraction of venom, purification and therapeutic dose preparation. 3. Polarization of extract and quality control of Polarization 4. Manufacturing, quality control, warehouse and shipment. ]]> Wed, 02 Nov 2016 07:15:24 GMT /slideshow/stages-of-production-of-escozine-for-pets/68041394 petlifepharma@slideshare.net(petlifepharma) Stages of Production of Escozine For Petsâ„¢ petlifepharma Escozine for Petsâ„¢ has 4 major production steps. 1. Collection of Scorpions from the Scorpion Reservation. 2. Extraction of venom, purification and therapeutic dose preparation. 3. Polarization of extract and quality control of Polarization 4. Manufacturing, quality control, warehouse and shipment. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/stagesofproduction-161102071524-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Escozine for Petsâ„¢ has 4 major production steps. 1. Collection of Scorpions from the Scorpion Reservation. 2. Extraction of venom, purification and therapeutic dose preparation. 3. Polarization of extract and quality control of Polarization 4. Manufacturing, quality control, warehouse and shipment.
Stages of Production of Escozine For Petsâ„¢ from PetLife Pharmaceuticals Inc
]]> 283 6 https://cdn.slidesharecdn.com/ss_thumbnails/stagesofproduction-161102071524-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 History of escozine for petsâ„¢ /petlifepharma/history-of-escozine-for-pets historyofescozineforpets-161015030200
The information contained in this document is subject to national and International Copyright© laws and is the proprietary and exclusive property of PetLife Pharmaceuticals, except as otherwise indicated. No part of this document, in whole or in part, may be reproduced, stored, transmitted, or used for design purposes without the prior written permission of PetLife Pharmaceuticals. The information contained in this document is subject to change without notice. The information in this document is provided for informational purposes only. Privacy Information: This document may contain information of a sensitive nature. This information should not be given to persons other than those who are involved with PetLife Pharmaceuticals, or who will become involved during the lifecycle. ]]>
The information contained in this document is subject to national and International Copyright© laws and is the proprietary and exclusive property of PetLife Pharmaceuticals, except as otherwise indicated. No part of this document, in whole or in part, may be reproduced, stored, transmitted, or used for design purposes without the prior written permission of PetLife Pharmaceuticals. The information contained in this document is subject to change without notice. The information in this document is provided for informational purposes only. Privacy Information: This document may contain information of a sensitive nature. This information should not be given to persons other than those who are involved with PetLife Pharmaceuticals, or who will become involved during the lifecycle. ]]> Sat, 15 Oct 2016 03:02:00 GMT /petlifepharma/history-of-escozine-for-pets petlifepharma@slideshare.net(petlifepharma) History of escozine for pets™ petlifepharma The information contained in this document is subject to national and International Copyright© laws and is the proprietary and exclusive property of PetLife Pharmaceuticals, except as otherwise indicated. No part of this document, in whole or in part, may be reproduced, stored, transmitted, or used for design purposes without the prior written permission of PetLife Pharmaceuticals. The information contained in this document is subject to change without notice. The information in this document is provided for informational purposes only. Privacy Information: This document may contain information of a sensitive nature. This information should not be given to persons other than those who are involved with PetLife Pharmaceuticals, or who will become involved during the lifecycle. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/historyofescozineforpets-161015030200-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The information contained in this document is subject to national and International Copyright© laws and is the proprietary and exclusive property of PetLife Pharmaceuticals, except as otherwise indicated. No part of this document, in whole or in part, may be reproduced, stored, transmitted, or used for design purposes without the prior written permission of PetLife Pharmaceuticals. The information contained in this document is subject to change without notice. The information in this document is provided for informational purposes only. Privacy Information: This document may contain information of a sensitive nature. This information should not be given to persons other than those who are involved with PetLife Pharmaceuticals, or who will become involved during the lifecycle.
History of escozine for petsâ„¢ from PetLife Pharmaceuticals Inc
]]> 198 9 https://cdn.slidesharecdn.com/ss_thumbnails/historyofescozineforpets-161015030200-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Medical review of medolife’s escozine tm technology in pre clinical &amp; clinical studies. /slideshow/medical-review-of-medolifes-escozine-tm-technology-in-pre-clinical-amp-clinical-studies/66331492 medicalreviewofmedolifesescozinetmtechnologyinpre-clinicalclinicalstudies-160923071546
ESCOZINETM is an innovative polarized, potentiated bio-active peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps) which contains amino acids, proteins and minerals. Medolife filed a patent in 2012 for its ESCOZINETM and polarization technology (Patent # US 8,097,284 B2). The polarization technique acts as a delivery system and additionally, amplifies the highly positive]]>
ESCOZINETM is an innovative polarized, potentiated bio-active peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps) which contains amino acids, proteins and minerals. Medolife filed a patent in 2012 for its ESCOZINETM and polarization technology (Patent # US 8,097,284 B2). The polarization technique acts as a delivery system and additionally, amplifies the highly positive]]> Fri, 23 Sep 2016 07:15:46 GMT /slideshow/medical-review-of-medolifes-escozine-tm-technology-in-pre-clinical-amp-clinical-studies/66331492 petlifepharma@slideshare.net(petlifepharma) Medical review of medolife’s escozine tm technology in pre clinical &amp; clinical studies. petlifepharma ESCOZINETM is an innovative polarized, potentiated bio-active peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps) which contains amino acids, proteins and minerals. Medolife filed a patent in 2012 for its ESCOZINETM and polarization technology (Patent # US 8,097,284 B2). The polarization technique acts as a delivery system and additionally, amplifies the highly positive <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/medicalreviewofmedolifesescozinetmtechnologyinpre-clinicalclinicalstudies-160923071546-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> ESCOZINETM is an innovative polarized, potentiated bio-active peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps) which contains amino acids, proteins and minerals. Medolife filed a patent in 2012 for its ESCOZINETM and polarization technology (Patent # US 8,097,284 B2). The polarization technique acts as a delivery system and additionally, amplifies the highly positive
Medical review of medolife’s escozine tm technology in pre clinical &amp; clinical studies. from PetLife Pharmaceuticals Inc
]]> 1248 7 https://cdn.slidesharecdn.com/ss_thumbnails/medicalreviewofmedolifesescozinetmtechnologyinpre-clinicalclinicalstudies-160923071546-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Petlife investor presentation /slideshow/petlife-investor-presentation/66003582 petlifeinvestorpresentation-160914060348
This document is being provided by PetLife solely for the information of those persons to whom it is transmitted. No person in any jurisdiction may treat this document as constituting either an offer to sell or solicitation of an offer to buy any securities in the Company. A prospective subscriber must rely solely on the terms of and disclosure of information including important information regarding risks and conflicts of interest contained in the Company's final offering memorandum and related documents, the only basis on which subscriptions may be made. ]]>
This document is being provided by PetLife solely for the information of those persons to whom it is transmitted. No person in any jurisdiction may treat this document as constituting either an offer to sell or solicitation of an offer to buy any securities in the Company. A prospective subscriber must rely solely on the terms of and disclosure of information including important information regarding risks and conflicts of interest contained in the Company's final offering memorandum and related documents, the only basis on which subscriptions may be made. ]]> Wed, 14 Sep 2016 06:03:48 GMT /slideshow/petlife-investor-presentation/66003582 petlifepharma@slideshare.net(petlifepharma) Petlife investor presentation petlifepharma This document is being provided by PetLife solely for the information of those persons to whom it is transmitted. No person in any jurisdiction may treat this document as constituting either an offer to sell or solicitation of an offer to buy any securities in the Company. A prospective subscriber must rely solely on the terms of and disclosure of information including important information regarding risks and conflicts of interest contained in the Company's final offering memorandum and related documents, the only basis on which subscriptions may be made. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/petlifeinvestorpresentation-160914060348-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This document is being provided by PetLife solely for the information of those persons to whom it is transmitted. No person in any jurisdiction may treat this document as constituting either an offer to sell or solicitation of an offer to buy any securities in the Company. A prospective subscriber must rely solely on the terms of and disclosure of information including important information regarding risks and conflicts of interest contained in the Company&#39;s final offering memorandum and related documents, the only basis on which subscriptions may be made.
Petlife investor presentation from PetLife Pharmaceuticals Inc
]]> 279 13 https://cdn.slidesharecdn.com/ss_thumbnails/petlifeinvestorpresentation-160914060348-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pet life pharmaceuticals inc /slideshow/pet-life-pharmaceuticals-inc-65221961/65221961 petlifepharmaceuticalsinc-160822054804
PetLife Pharmaceuticals, Inc. (PetLife Pharma) has developed and is launching a new generation of potentiated veterinary cancer medications and nutraceuticals. ]]>
PetLife Pharmaceuticals, Inc. (PetLife Pharma) has developed and is launching a new generation of potentiated veterinary cancer medications and nutraceuticals. ]]> Mon, 22 Aug 2016 05:48:04 GMT /slideshow/pet-life-pharmaceuticals-inc-65221961/65221961 petlifepharma@slideshare.net(petlifepharma) Pet life pharmaceuticals inc petlifepharma PetLife Pharmaceuticals, Inc. (PetLife Pharma) has developed and is launching a new generation of potentiated veterinary cancer medications and nutraceuticals. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/petlifepharmaceuticalsinc-160822054804-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> PetLife Pharmaceuticals, Inc. (PetLife Pharma) has developed and is launching a new generation of potentiated veterinary cancer medications and nutraceuticals.
Pet life pharmaceuticals inc from PetLife Pharmaceuticals Inc
]]> 209 13 https://cdn.slidesharecdn.com/ss_thumbnails/petlifepharmaceuticalsinc-160822054804-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pet life pharmaceuticals inc /slideshow/pet-life-pharmaceuticals-inc/64931817 petlifepharmaceuticalsinc-160812072226
PetLife Pharmaceuticals, Inc. (PetLife Pharma) has developed and is launching a new generation of potentiated veterinary cancer medications and nutraceuticals. ]]>
PetLife Pharmaceuticals, Inc. (PetLife Pharma) has developed and is launching a new generation of potentiated veterinary cancer medications and nutraceuticals. ]]> Fri, 12 Aug 2016 07:22:26 GMT /slideshow/pet-life-pharmaceuticals-inc/64931817 petlifepharma@slideshare.net(petlifepharma) Pet life pharmaceuticals inc petlifepharma PetLife Pharmaceuticals, Inc. (PetLife Pharma) has developed and is launching a new generation of potentiated veterinary cancer medications and nutraceuticals. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/petlifepharmaceuticalsinc-160812072226-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> PetLife Pharmaceuticals, Inc. (PetLife Pharma) has developed and is launching a new generation of potentiated veterinary cancer medications and nutraceuticals.
Pet life pharmaceuticals inc from PetLife Pharmaceuticals Inc
]]> 141 4 https://cdn.slidesharecdn.com/ss_thumbnails/petlifepharmaceuticalsinc-160812072226-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Medolife International Bio-Pharmaceutical Company /slideshow/medolife-international-biopharmaceutical-company/64387091 escozine-patent-160726084632
Has received an application/or a patentjor a new and us~ful invention. The title and description of the invention are enclosed. The requirements of law have been complied with, and it has been determined that a patent on the invention shall be granted under the law.]]>
Has received an application/or a patentjor a new and us~ful invention. The title and description of the invention are enclosed. The requirements of law have been complied with, and it has been determined that a patent on the invention shall be granted under the law.]]> Tue, 26 Jul 2016 08:46:32 GMT /slideshow/medolife-international-biopharmaceutical-company/64387091 petlifepharma@slideshare.net(petlifepharma) Medolife International Bio-Pharmaceutical Company petlifepharma Has received an application/or a patentjor a new and us~ful invention. The title and description of the invention are enclosed. The requirements of law have been complied with, and it has been determined that a patent on the invention shall be granted under the law. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/escozine-patent-160726084632-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Has received an application/or a patentjor a new and us~ful invention. The title and description of the invention are enclosed. The requirements of law have been complied with, and it has been determined that a patent on the invention shall be granted under the law.
Medolife International Bio-Pharmaceutical Company from PetLife Pharmaceuticals Inc
]]> 705 13 https://cdn.slidesharecdn.com/ss_thumbnails/escozine-patent-160726084632-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-petlifepharma-48x48.jpg?cb=1523391618 PetLife Pharmaceuticals, Inc. is a registered U.S Veterinary Pharmaceutical company whose mission is to bring its scientifically proven, potentiated bio active medication and nutraceuticals to treat cancer in pets. www.petlifepharma.com/ https://cdn.slidesharecdn.com/ss_thumbnails/petlifepharmaceuticalsispleasedtoannouncethecompletionofthenewcompanywebsite-161110064023-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/pet-life-pharmaceuticals-is-pleased-to-announce-the-completion-of-the-new-company-website/68547193 Pet life pharmaceutica... https://cdn.slidesharecdn.com/ss_thumbnails/stagesofproduction-161102071524-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/stages-of-production-of-escozine-for-pets/68041394 Stages of Production o... https://cdn.slidesharecdn.com/ss_thumbnails/historyofescozineforpets-161015030200-thumbnail.jpg?width=320&height=320&fit=bounds petlifepharma/history-of-escozine-for-pets History of escozine fo...